Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF7 | Erlotinib | 3.1623 | uM | 10 | 156.25 | 46.73 | 111.00 | 122.25 | 0.9080 | 0.8656 |
| MCF7 | Lapatinib | 1 | uM | 10 | 156.25 | 46.73 | 115.00 | 122.25 | 0.9407 | 0.9138 |
| MCF7 | Lapatinib | 0.31623 | uM | 10 | 156.25 | 46.73 | 170.00 | 122.25 | 1.3906 | 1.5365 |
| MCF7 | Erlotinib | 10 | uM | 10 | 156.25 | 46.73 | 170.00 | 122.25 | 1.3906 | 1.5365 |
| MCF7 | Erlotinib | 19.9526 | uM | 10 | 156.25 | 46.73 | 149.00 | 122.25 | 1.2188 | 1.3066 |
| MCF7 | 17-AAG | 0.0016596 | uM | 10 | 156.25 | 46.73 | 143.00 | 122.25 | 1.1697 | 1.2392 |
| MCF7 | 17-AAG | 10 | uM | 10 | 156.25 | 46.73 | 62.00 | 122.25 | 0.5072 | 0.2261 |
| MCF7 | Linsitinib | 0.01 | uM | 10 | 156.25 | 46.73 | 261.00 | 122.25 | 2.1350 | 2.4549 |
| MCF7 | 0 | uM | 10 | 156.25 | 46.73 | 130.00 | 122.25 | 1.0634 | 1.0906 | |
| MCF7 | Linsitinib | 10 | uM | 10 | 156.25 | 46.73 | 75.00 | 122.25 | 0.6135 | 0.4064 |
| MCF7 | Linsitinib | 19.9526 | uM | 10 | 156.25 | 46.73 | 42.00 | 122.25 | 0.3436 | -0.0740 |
| MCF7 | Erlotinib | 0.31623 | uM | 10 | 156.25 | 46.73 | 163.00 | 122.25 | 1.3333 | 1.4608 |
| MCF7 | 17-AAG | 0.0033113 | uM | 10 | 156.25 | 46.73 | 69.00 | 122.25 | 0.5644 | 0.3244 |
| MCF7 | 0 | uM | 10 | 156.25 | 46.73 | 131.00 | 122.25 | 1.0716 | 1.1022 | |
| MCF7 | 0 | uM | 10 | 156.25 | 46.73 | 97.00 | 122.25 | 0.7935 | 0.6928 | |
| MCF7 | 0 | uM | 10 | 156.25 | 46.73 | 74.00 | 122.25 | 0.6053 | 0.3928 | |
| MCF7 | 17-AAG | 0.01 | uM | 10 | 156.25 | 46.73 | 40.00 | 122.25 | 0.3272 | -0.1060 |
| MCF7 | 17-AAG | 0.31623 | uM | 10 | 156.25 | 46.73 | 36.00 | 122.25 | 0.2945 | -0.1714 |
| MCF7 | 17-AAG | 0.1 | uM | 10 | 156.25 | 46.73 | 67.00 | 122.25 | 0.5481 | 0.2966 |
| MCF7 | Erlotinib | 0.031623 | uM | 10 | 156.25 | 46.73 | 138.00 | 122.25 | 1.1288 | 1.1825 |
| MCF7 | Erlotinib | 1 | uM | 10 | 156.25 | 46.73 | 190.00 | 122.25 | 1.5542 | 1.7482 |
| MCF7 | Linsitinib | 0.31623 | uM | 10 | 156.25 | 46.73 | 131.00 | 122.25 | 1.0716 | 1.1022 |
| MCF7 | Lapatinib | 3.1623 | uM | 10 | 156.25 | 46.73 | 129.00 | 122.25 | 1.0552 | 1.0790 |
| MCF7 | 17-AAG | 0.031623 | uM | 10 | 156.25 | 46.73 | 76.00 | 122.25 | 0.6217 | 0.4199 |
| MCF7 | Erlotinib | 0.1 | uM | 10 | 156.25 | 46.73 | 118.00 | 122.25 | 0.9652 | 0.9496 |